Comment on

• Software-guided insulin dosing: tight glycemic control and decreased glycemic derangements in critically ill patients.

  Saur NM, Kongable GL, Holewinski S, O'Brien K, Nasraway SA Jr. Saur NM, et al. Mayo Clin Proc. 2013 Sep;88(9):920-9. doi: 10.1016/j.mayocp.2013.07.003. Mayo Clin Proc. 2013. PMID: 24001484 Clinical Trial.
• Association of dysglycemia and all-cause mortality across the spectrum of coronary artery disease.

  Yang SW, Zhou YJ, Tian XF, Pan GZ, Liu YY, Zhang J, Guo ZF, Chen SY, Gao ST, Du J, Jia DA, Fang Z, Hu B, Han HY, Gao F, Hu DY, Xu YY; Beijing Heart and Metabolism Survey Study Group. Yang SW, et al. Mayo Clin Proc. 2013 Sep;88(9):930-41. doi: 10.1016/j.mayocp.2013.05.022. Mayo Clin Proc. 2013. PMID: 24001485
• Objectively measured physical activity and inflammatory markers among US adults with diabetes: implications for attenuating disease progression.

  Loprinzi PD, Ramulu PY. Loprinzi PD, et al. Mayo Clin Proc. 2013 Sep;88(9):942-51. doi: 10.1016/j.mayocp.2013.05.015. Mayo Clin Proc. 2013. PMID: 24001486